Context Sudden cardiac death after myocardial infarction (MI) has not been assessed recently in the community. Risk stratification for sudden cardiac death after MI commonly relies on baseline characteristics and little is known about the relationship between recurrent ischemia or heart failure and sudden cardiac death.
Objective To evaluate the risk of sudden cardiac death after MI and the impact of recurrent ischemia and heart failure on sudden cardiac death.
Design, Setting, and Participants Population-based surveillance study of 2997 residents (mean [SD] age, 67 [14] years; 59% were men) experiencing an MI in Olmsted County, Minnesota, between 1979 and 2005, and followed up through February 29, 2008.
Main Outcome Measures Sudden cardiac death defined as out-of-hospital death due to coronary disease; and observed survival free of sudden cardiac death compared with that expected in Olmsted County, Minnesota.
Results During a median follow-up of 4.7 years (25th-75th percentile, 1.6-7.1 years), 1160 deaths occurred, 282 from sudden cardiac death (24%). The 30-day cumulative incidence of sudden cardiac death was 1.2% (95% confidence interval [CI], 0.8%-1.6%). Thereafter, the rate of sudden cardiac death was constant at 1.2% per year yielding a 5-year cumulative incidence of 6.9% (95% CI, 5.9%-7.9%). The 30-day incidence of sudden cardiac death was 4-fold higher than expected (standardized mortality ratio, 4.2; 95% CI, 2.9-5.8). The risk of sudden cardiac death has declined significantly over time (hazard ratio [HR], 0.62 [95% CI, 0.44-0.88] for MIs that occurred between 1997 and 2005 compared with between 1979 and 1987; P = .03). The recurrent events of ischemia (n = 842), heart failure (n = 365), or both (n = 873) occurred in 2080 patients. After adjustment for baseline characteristics, recurrent ischemia was not associated with sudden cardiac death (HR, 1.26 [95% CI, 0.96-1.65]; P = .09), while heart failure markedly increased the risk of sudden cardiac death (HR, 4.20 [95% CI, 3.10-5.69]; P < .001).
Conclusions The risk of sudden cardiac death following MI in community practice has declined significantly over the past 30 years. Sudden cardiac death is independently associated with heart failure but not with recurrent ischemia.
Sudden cardiac death is a devastating complication of myocardial infarction (MI).1 Long-term population studies outlining the incidence of sudden cardiac death after MI in the community are decades old.2-6 Since the publication of these reports, the in-hospital mortality after MI has decreased substantially because of evidence-based therapies, yielding a growing number of MI survivors potentially at risk for sudden cardiac death.7-11 Incidence and predictors of sudden cardiac death after MI recently have been examined in large clinical trials12-14 and among patients from tertiary care centers.15-18 However, these selected patients may not be representative of patients in the community.19 Thus, in an era when the long-term prognosis after MI has greatly improved, community-based data reflecting the contemporary risk of sudden cardiac death after MI are lacking.
Determining the risk of sudden cardiac death after MI remains challenging.20 Implantable cardioverter-defibrillators (ICDs) decrease mortality in patients with reduced ejection fraction. However, most patients receiving an ICD for primary prevention of sudden cardiac death do not use the devices to terminate cardiac tachyarrhythmias,21 at least not during the period of follow-up during most trials. Further, recent data from the Defibrillator in Acute Myocardial Infarction Trial (DINAMIT)22 and the second Multicenter Automatic Defibrillator Implantation Trial (MADIT-II)23 show that ICD placement less than 40 days after an MI does not reduce mortality, suggesting that sudden cardiac death risk after MI is dependent on time.24,25 One issue with current risk prediction approaches for sudden cardiac death is that predictions based solely on characteristics assessed at baseline, shortly after the MI, may be insufficient. This leads to our hypothesis, as yet untested, that intercurrent events such as recurrent ischemia and heart failure occurring after the index MI increase the risk of sudden cardiac death.
The objectives of our investigation were to address the aforementioned gaps in knowledge within a population-based surveillance study of all patients who had an MI in Olmsted County, Minnesota, between 1979 and 2005. Specifically, we set out to define the burden of sudden cardiac death after MI in the community, to examine if it changed over time, and to assess its relationship with intercurrent ischemia and heart failure after MI.
Epidemiological research is possible in Olmsted County, Minnesota, because the county is relatively isolated from other urban centers and nearly all medical care is delivered to local residents by a small number of health care providers. Except for the fact that a higher proportion of the working population is employed in the health care industry, the characteristics of the population of Olmsted County, Minnesota, are similar to those of white persons in the United States (http://www.census.gov). All medical care providers, including the Mayo Medical Center, the Olmsted Medical Group, and its affiliated Olmsted Community Hospital, use a unit medical record system. Thus, detailed information on all inpatient, outpatient, and emergency department visits, and all laboratory results, pathology reports, correspondence, and records of physician visits to nursing homes or private homes are kept in one place. Since the early 1960s, extensive indices based on clinical or histological diagnosis, surgical procedures, and billing data also have been kept for all providers of health care under the auspices of the Rochester Epidemiology Project.26 This allows linkage of information from essentially all sources of heath care available to and used by the residents of Olmsted County, Minnesota, and provides a unique infrastructure for analyzing disease determinants and outcomes.
Methods used in the identification of patients with incident MI have been published before.26 Briefly, lists of patients discharged from Olmsted County, Minnesota, hospitals between 1979 and 2005 with a diagnosis compatible with MI were obtained from the Rochester Epidemiology Project index of diagnoses. The target International Classification of Diseases, Ninth Revision codes were 410 (acute MI), 411 (other acute and subacute forms of ischemic heart disease), 412 (old MI), 413 (angina pectoris), and 414 (other forms of ischemic heart disease). All events coded as 410, a 50% random sample of codes 411, and a 10% random sample of codes 412, 413, and 414 were reviewed. The sampling fractions were similar to those used in other studies.27 Minnesota law requires obtaining general research authorization from every patient before the release of any information from medical records for research purposes. Because this study did not include patient contact, no specific consent was necessary. The Mayo Clinic and Olmsted Medical Center institutional review boards reviewed and approved all aspects of the study.
To ascertain the incident MI status, medical records were reviewed by abstractors and data on cardiac pain, cardiac biomarkers, and electrocardiogram results were obtained. All electrocardiograms were interpreted according to the Minnesota code.28 Standard criteria were applied to assign an MI diagnosis based on these data. Information on the reliability of these criteria has been published before.11
Clinical Data and Intercurrent Cardiac Events
Baseline demographic and clinical characteristics, including hypertension, hyperlipidemia, smoking status, diabetes mellitus, obesity, family history of coronary heart disease, Killip class, and other comorbidities at the time of index MI, were recorded from physicians' clinical notes. Total comorbidity burden was summarized by the Charlson comorbidity index.29
The first episodes of intercurrent cardiac events that occurred after the incident MI were recorded. Heart failure was diagnosed using the Framingham Heart Study criteria requiring the simultaneous presence of at least 2 major criteria (ie, paroxysmal nocturnal dyspnea or orthopnea, neck vein distension, rales, cardiomegaly, acute pulmonary edema, S3 gallop, venous pressure ≥16 cm H2O, hepatojugular reflux) or 1 major criterion with 2 minor criteria (ie, ankle edema, night cough, dyspnea upon exertion, hepatomegaly, pleural effusion, vital capacity decreased by one-third from maximum, heart rate ≥120/min).30 Recurrent ischemia was defined as hospitalization for recurrent MI or unstable angina using the physicians' diagnosis.31,32
Follow-up and Ascertainment of Sudden Death
All patients were followed up until death or the date of the last follow-up as ascertained by reviewing the entire community medical records. The final date of follow-up was February 29, 2008. All death certificate data obtained from the Minnesota Department of Health were searched to identify individuals older than 25 years who were listed as residents of Olmsted County, Minnesota, at the time of death. Information on age and sex of the decedent and the date, site, and underlying cause of death, as determined by the state nosologist, was collected. Since 1968, all death certificates issued in Minnesota have described the site of death. Out-of-hospital deaths were defined as those occurring outside of acute care or long-term care hospitals, including deaths occurring in emergency departments, private homes, public places, nursing or boarding care homes, and infirmaries, as well as deaths among persons declared dead on arrival at a hospital. Sudden cardiac death was defined as out-of-hospital deaths whose primary cause of death was classified as coronary heart disease on the death certificate (International Classification of Diseases, Ninth Revision codes 410-414). This definition, previously validated in the Olmsted County, Minnesota, population, provides a robust positive predictive value for sudden cardiac death due to coronary heart disease occurring within 24 hours of the onset of symptoms.33
Data are presented as frequency or as mean and standard deviation. Patients who died in the hospital and could not by design meet criteria for sudden cardiac death were not included. The analysis thus pertained to hospital survivors. Characteristics of patients who died suddenly were compared with those who survived or died of other causes with proportional hazards regression. Survival free of sudden cardiac death was analyzed while treating deaths from other causes as a competing risk; and survival free of recurrent ischemic events and heart failure was analyzed by treating all deaths as a competing risk.34 The risk of sudden cardiac death after MI was compared with the risk of sudden cardiac death in the general population of Olmsted County, Minnesota, matched on age and sex, and expressed as a standardized mortality ratio.
Predictors of sudden cardiac death were assessed by Cox proportional hazards regression, with recurrent ischemic events and heart failure treated as time-dependent covariates. Heart failure that occurred after hospitalization for MI but before dismissal from the hospital was included as an intercurrent event. In the model, patients were treated as being at risk for sudden cardiac death after hospital dismissal. Interactions between year of MI and all predictor variables were tested. Only the year × age interaction was found to be significant. The proportional hazards assumption was assessed using the Schoenfeld residuals and found to be valid. Additive hazard models were used to assess the absolute increment in sudden cardiac death risk associated with intercurrent events. Differences in the baseline hazard were observed before and after 30 days after hospital dismissal, so time epochs were created for the first 30 days after MI and yearly thereafter. The additive model was fit in terms of event rate per epoch. A P value of less than .05 was considered statistically significant. Analyses were performed using SAS version 8.2 (SAS Institute Inc, Cary, North Carolina) and S-PLUS version 8.0.1 (TIBCO Software, Palo Alto, California).
Between 1979 and 2005, a total of 3296 incident MIs occurred in Olmsted County, Minnesota; 299 died in the hospital, leaving 2997 hospital survivors as the study population. At the time of index MI, these patients had a mean (SD) age of 67 (14) years and 59% were men. Cardiovascular risk factors were prevalent and 59% of the patients had at least 1 comorbid condition. Most cases in this community cohort presented electrocardiographically as non–ST-segment elevation MIs (Table 1). Approximately half were treated with reperfusion or revascularization: 1156 underwent percutaneous coronary intervention (39%), 282 underwent coronary artery bypass grafting (9%), and 318 were treated with thrombolytics (11%).
Incidence of Sudden Death After MI
Over a median follow-up of 4.7 years (25th-75th percentile, 1.6-7.1 years), 1160 deaths occurred, 282 of which were classified as sudden cardiac death (24%). During the first 30 days after hospital dismissal, 35 sudden cardiac deaths occurred for a cumulative incidence of 1.2% (95% confidence interval [CI], 0.8%-1.6%) in the first month. Thereafter, the rate of sudden cardiac death was constant at 1.2% per year. Figure 1 shows the cumulative incidence of sudden cardiac death, treating other causes of death as a competing risk. At 1 year, the cumulative incidence of sudden cardiac death was 3.0% (95% CI, 2.4%-3.7%). At 5 years, the cumulative incidence of sudden cardiac death was 6.9% (95% CI, 5.9%-7.9%).
Patients who experienced sudden cardiac death were older, more likely to be women, and to have a history of hypertension, diabetes mellitus, and other comorbidities (Table 1). They were more likely to present in a higher Killip class and with an anterior MI. Patients who experienced sudden cardiac death were less likely to have been treated with reperfusion or revascularization.
The risk of sudden cardiac death after MI decreased during the 27 years of the study period. With MIs that occurred between 1979 and 1987 as the reference and after adjusting for age, the risk of sudden cardiac death was 20% lower (hazard ratio [HR], 0.80; 95% CI, 0.60-1.07) for MIs that occurred between 1988 and 1996 and 38% lower (HR, 0.62; 95% CI, 0.44-0.88) for MIs that occurred between 1997 and 2005 (P = .03).
Risk of Sudden Death After MI Compared With the General Population
In the first 30 days after hospital dismissal, the 35 sudden cardiac deaths that were enumerated represent more than a 4-fold increase in the risk of sudden cardiac death when compared with the 8 sudden cardiac deaths expected among age- and sex-matched individuals within the same source population of Olmsted County, Minnesota (standardized mortality ratio, 4.2; 95% CI, 2.9-5.8). In the year thereafter, the risk of sudden cardiac death after MI was lower than that expected in the general population (standardized mortality ratio, 0.66; 95% CI, 0.50-0.85) and remained lower than expected in the following years (Table 2).
Intercurrent Events and Sudden Death
Intercurrent cardiac events occurred frequently after MI (2080 of the 2997 patients; 69%). A total of 842 patients had recurrent ischemia alone, 365 had heart failure alone, and 873 had both events. Among the patients who experienced both events, the events occurred within 30 days of each other in 378 patients (43%). For recurrent ischemia, the 30-day cumulative incidence was 28% (95% CI, 26%-29%) and the 1-year cumulative incidence was 42% (95% CI, 41%-44%) (Figure 2). Beyond the first year after the MI, the cumulative incidence of recurrent ischemia exhibited a constant increase with a 5-year cumulative incidence of 56% (95% CI, 55%-58%). This equates to a yearly rate of recurrent ischemia of 3.5% beyond the first year after MI. Recurrent ischemia during follow-up was associated with an increased risk of sudden cardiac death (HR, 1.31 [95% CI, 1.01-1.71]; P = .04). After adjusting for baseline clinical characteristics (age, sex, year of MI, hypertension, diabetes mellitus, comorbidity, Killip class, reperfusion or revascularization, and heart failure after MI), the association between sudden cardiac death and recurrent ischemia was attenuated and became nonsignificant (HR, 1.26 [95% CI, 0.96-1.65]; P = .09) (Table 3).
For heart failure, the 30-day cumulative incidence was 26% (95% CI, 24%-27%) and at 5 years it was 38% (95% CI, 37%-40%) (Figure 2). This equates to a yearly heart failure rate of 2.4% beyond the first 30 days after MI. Heart failure exhibited a strong adverse association with sudden cardiac death (HR, 8.1 [95% CI, 6.2-10.6]; P < .001), which remained strong after adjustment for baseline clinical characteristics (age, sex, year of MI, hypertension, diabetes mellitus, comorbidity, Killip class, reperfusion or revascularization, and recurrent ischemia after MI) (HR, 4.20 [95% CI, 3.10-5.69]; P < .001) (Table 3). Expressed in terms of absolute risk and compared with patients who did not experience heart failure during follow-up, the absolute risk of sudden cardiac death for patients with heart failure was on average 2.5% (95% CI, 1.9%-3.1%; P < .001) higher in the first 30 days after MI, and in each year thereafter.
Given the aforementioned temporal decline in the risk of sudden cardiac death, we then examined the absolute risks of sudden cardiac death according to the presence or absence of heart failure by time. Considering 75-year-old patients experiencing an MI between 1979 and 1987 as an example, the absolute risk of sudden cardiac death for those with heart failure was 4.3% (95% CI, 3.6%-5.1%) within the first 30 days after MI and in each year thereafter compared with an absolute risk of sudden cardiac death of 1.9% (95% CI, 1.3%-2.4%) among those who did not experience heart failure. For 75-year-old patients experiencing an MI between 1988 and 1996, the absolute risk of sudden cardiac death was 3.7% (95% CI, 3.0%-4.4%) and 1.2% (95% CI, 0.7%-1.6%) for those experiencing and not experiencing heart failure, respectively. Finally, for 75-year-old patients experiencing an MI during the most recent period (1997-2005), the absolute risk of sudden cardiac death was 2.4% (95% CI, 1.7%-3.2%) and 0% (95% CI, −0.7% to 0.6%) depending on the occurrence or nonoccurrence of heart failure, respectively.
For the 1204 MIs occurring between 1988 and 1998, left ventricular systolic function was assessed among 693 patients (58%) within 30 days after index MI. Of these, 337 patients (49%) had left ventricular ejection fraction below 50%. When left ventricular ejection fraction was included in the multivariate analysis, there was no change in the association between sudden cardiac death and intercurrent cardiac events (recurrent ischemia HR, 1.60 [95% CI, 0.90-2.82]; P = .11 and heart failure HR, 3.64 [95% CI, 1.71-7.75]; P < .001). In particular, the strength of the association between heart failure and sudden cardiac death remained strong. Fifty patients had defibrillators implanted before their last follow-up date. All analyses were repeated while excluding these patients and yielded similar results.
The present data, which represent the experience of a large, community-based incidence cohort, indicate that the risk of sudden cardiac death after MI is the highest during the first month, when it markedly exceeds that noted in the general population. Thereafter, however, among 30-day survivors, the risk of sudden cardiac death declines markedly to 1.2% per year, lower than that expected in the general population. Furthermore, the risk of sudden cardiac death after MI has declined by more than 40% over the past quarter of a century, a decline that predates the widespread use of defibrillators but parallels drastic changes in medical therapy for acute MI, including reperfusion and secondary prevention. While the risk of sudden cardiac death beyond the first 30 days is low, it is markedly increased by the occurrence of heart failure during follow-up, which underscores the importance of continued surveillance of patients after MI and the dynamic nature of risk stratification.
The rather sparse community data on the incidence of sudden cardiac death after MI largely predate the widespread use of evidence-based treatment for MI. In the Framingham Heart Study, the 5-year cumulative incidence of sudden cardiac death was approximately 7%,3 using a conservative definition of sudden cardiac death whereby only deaths within 1 hour of symptom onset were included. In the Multicenter Post Infarction Program, conducted in the 1980s, sudden cardiac deaths were more frequent (3.6% per year).5 More recently, in a cohort study of MI patients discharged from several Canadian medical centers, sudden cardiac death occurred at a rate of 1.9% per year, a figure consistent with the present data.15 On the other hand, sudden cardiac death after MI was less common (<1% per year) among patients discharged after optimal treatment, including revascularization and medical therapy, in single-center European studies.15,17
These differences across studies likely reflect multiple factors, including differences in definitions, differences in periods when studies were conducted, and differences between community experiences and single-center studies. Methodological issues notwithstanding, taken collectively, these reports indicate that beyond the first month after MI, sudden cardiac death is a rather infrequent albeit devastating complication. The present data augment previous reports by indicating that the risk of sudden cardiac death after MI has markedly declined over time and by providing a reference framework on the occurrence of sudden cardiac death among age- and sex-matched individuals from the same source population.
After the initial month after the MI event, the rate of sudden cardiac death becomes less than expected in the general population, most likely reflecting the well-known survivor bias effect, which is amplified as the duration of follow-up increases. With regard to the temporal decline in sudden cardiac death after MI, there was prior indirect evidence that this might be occurring. Indeed, whereas approximately 40% to 50% of all deaths after MI were due to sudden cardiac death in studies prior to the 1980s,5,6 this proportion has decreased to 20% to 30% in more contemporary cohorts including the present one.15,17,18 However, historical comparisons across cohorts are fraught with challenges because source populations often differ markedly, which can in turn explain differences in outcomes.
The present study, using the same population and robust, standardized methods of MI ascertainment, which have remained constant during the study period, directly demonstrates a profound reduction in the occurrence of sudden cardiac death after MI in a single population under rigorous surveillance. Importantly, the practice of implanting defibrillators is unlikely to have affected the present findings because their use was minimal in this cohort.
The risk of sudden cardiac death after MI is the highest during the first 30 days, as was underscored by data from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)13 and the Home Automated External Defibrillator Trial (HAT).35 Both of these trials focused on high-risk groups and indicated that the occurrence of sudden cardiac death among 30-day MI survivors was approximately 1% per year. The present community data extend these findings by indicating that in a community-based cohort, the risk of sudden cardiac death among all patients with MI is analogous to that of the highest risk groups in these trials, is highest early after the MI, and declines markedly thereafter. While these data may come across as seemingly at odds with the efficacy of ICD as reported in most randomized trials, interpreting the results of these trials is challenging as recently underscored.36
Intercurrent Cardiac Events
Intercurrent cardiac events are common after MI and remain common even in contemporary cohorts.32,37-40 The frequent occurrence of heart failure is of particular concern given its adverse impact on the occurrence of sudden cardiac death, which is far greater than and independent of risk factors that can be measured at the time of the index MI. In a recent report from MADIT-II, participants randomized to ICD were studied to assess the effects of intercurrent cardiac events on appropriate ICD discharges for ventricular tachycardia or fibrillation.41 After adjustment for numerous factors including left ventricular ejection fraction, New York Heart Association functional class, medications, and laboratory results, heart failure and recurrent ischemia were associated with a 2.5 and 1.5 times higher risk of device therapy, respectively.41 The findings presented herein support and amplify such previous reports by indicating that, in a community-based cohort, cardiac events during follow-up are associated with a marked increase in the risk of sudden cardiac death, particularly for heart failure, which increases the risk of sudden cardiac death by a factor of 4-fold. This increase in the risk related to the occurrence of heart failure cannot be fully interpreted without its integration within the appraisal of the absolute risk of sudden cardiac death, which is particularly high during the first month after MI. Indeed, understanding the excess risk conferred by heart failure requires integrating its relative risk with the absolute risk of the sudden cardiac death at a given point in time during follow-up.42 Thus, clinicians should be particularly concerned about the adverse impact of heart failure on sudden cardiac death when heart failure occurs early during follow-up.
Strengths and Limitations
The racial and ethnic composition of Olmsted County, Minnesota, may limit the generalization of these data to groups underrepresented in the population. While no single community can completely represent the nation as a whole, studies of chronic diseases in Olmsted County, Minnesota, indicate that results from the county can be extrapolated to a large part of the population. Left ventricular function was not uniformly assessed in all patients, consistent with current practice.43-46 However, an ancillary analysis restricted to persons with measurement of left ventricular function showed similar results.
Herein, we defined sudden cardiac death as out-of-hospital deaths whose primary cause of death was coronary heart disease.33 The validity of this method is quite robust for sudden cardiac death due to coronary disease occurring within 24 hours of symptom onset and this definition is analogous to that used by others.13 In our experience, using 1 hour as the time frame to determine the sudden nature of death could not be implemented with an acceptable level of accuracy. To the extent that individuals would have sought care prior to death, the presence of clinical, nonfatal conditions would have been taken into account in the analysis. It is conceivable that out-of-hospital deaths occurring after MI may be more likely to be coded as cardiac in origin. This limitation is shared by all studies addressing this subject. Importantly, the temporal trends in sudden cardiac death after MI is not affected by definitional issues because the definition of sudden cardiac death remained constant during the study period.
Our study also has a number of important strengths. The internal validity of the present data are quite robust because our ascertainment identified all consecutive incident MIs in the community evaluated according to rigorous validation criteria, which remained constant over time. Indeed, the present data represent the comprehensive experience of a community for more than 2 decades during a period that is minimally affected by the trials of defibrillator implant after MI, such that the present results are not influenced by this evolving practice. The availability of rich clinical follow-up for nonfatal clinical events that occur after the initial hospitalization is a distinct feature of the present community study because most other MI registries47,48 and surveillance studies9,10,49 seldom include clinical follow-up after hospitalization. This unique strength enabled us to integrate intercurrent clinical events after MI in the prediction of sudden cardiac death, which has important direct clinical implications for risk stratification. Indeed, these data underscore the dynamic nature of risk stratification and the crucial importance of clinicians reassessing patients' risks after MI if they develop heart failure. Finally, the innovative statistical methods applied herein, which build on extensive experience with survival analysis,50 allowed us to report on the absolute risk after MI, an important yet seldom reported element of risk stratification.42,51,52
To this end, the present data document that in contemporary times, the risk of sudden cardiac death after MI in the absence of intercurrent heart failure is quite low, which can help in decision making for primary prevention of sudden cardiac death among patients after MI.
In the community, the risk of sudden cardiac death is the highest during the first month after MI when it markedly exceeds the rate in the general population. Among 30-day survivors, the risk of sudden cardiac death declines rapidly but it is markedly increased by the occurrence of heart failure during follow-up. This underscores the importance of continued surveillance of patients after MI and the dynamic nature of risk stratification. Moreover, the risk of sudden cardiac death after MI has declined substantially over the past quarter of a century before the widespread use of defibrillators, which underscores the importance of evidence-based therapy for acute MI including reperfusion and secondary prevention.
Corresponding Author: Véronique L. Roger, MD, MPH, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (roger.veronique@mayo.edu).
Author Contributions: Dr Roger had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Adabag, Roger.
Acquisition of data: Roger.
Analysis and interpretation of data: Adabag, Therneau, Gersh, Weston, Roger.
Drafting of the manuscript: Adabag, Roger.
Critical revision of the manuscript for important intellectual content: Adabag, Therneau, Gersh, Weston, Roger.
Statistical analysis: Therneau, Weston.
Obtained funding: Roger.
Study supervision: Adabag, Roger.
Financial Disclosures: None reported.
Funding/Support: This study was supported by grant AR30582 from the Public Health Service and grants R01 HL 59205 and R01 HL 72435 from the National Institutes of Health. Dr Adabag is supported, in part, by VA Clinical Science R&D Service grant 04S-CRCOE 001. Dr Roger is an established investigator of the American Heart Association.
Role of the Sponsors: The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
1.Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias.
N Engl J Med. 2001;345(20):1473-148211794197
PubMedGoogle ScholarCrossref 3.Berger CJ, Murabito JM, Evans JC, Anderson KM, Levy D. Prognosis after first myocardial infarction: comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study.
JAMA. 1992;268(12):1545-15511518109
PubMedGoogle ScholarCrossref 4.Kannel WB, Sorlie P, McNamara PM. Prognosis after initial myocardial infarction: the Framingham study.
Am J Cardiol. 1979;44(1):53-59453046
PubMedGoogle ScholarCrossref 5.Marcus FI, Cobb LA, Edwards JE,
et al. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction.
Am J Cardiol. 1988;61(1):8-153337021
PubMedGoogle ScholarCrossref 6.Mukharji J, Rude RE, Poole WK,
et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up.
Am J Cardiol. 1984;54(1):31-366741836
PubMedGoogle ScholarCrossref 7.Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study.
Circulation. 2004;110(5):522-52715262842
PubMedGoogle ScholarCrossref 8.Gerber Y, Jacobsen SJ, Frye RL, Weston SA, Killian JM, Roger VL. Secular trends in deaths from cardiovascular diseases: a 25-year community study.
Circulation. 2006;113(19):2285-229216682616
PubMedGoogle ScholarCrossref 9.Goldberg RJ, Gorak EJ, Yarzebski J,
et al. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.
Circulation. 1993;87(6):1947-19538504508
PubMedGoogle ScholarCrossref 10.McGovern PG, Pankow JS, Shahar E,
et al; Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease–mortality, morbidity, medical care, and risk factors.
N Engl J Med. 1996;334(14):884-8908596571
PubMedGoogle ScholarCrossref 11.Roger VL, Jacobsen SJ, Weston SA,
et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994.
Ann Intern Med. 2002;136(5):341-34811874305
PubMedGoogle ScholarCrossref 12.Abildstrom SZ, Rask-Madsen C, Ottesen MM,
et al. Impact of age and sex on sudden cardiovascular death following myocardial infarction.
Heart. 2002;88(6):573-57812433881
PubMedGoogle ScholarCrossref 13.Solomon SD, Zelenkofske S, McMurray JJ,
et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
N Engl J Med. 2005;352(25):2581-258815972864
PubMedGoogle ScholarCrossref 14.Yap YG, Duong T, Bland M,
et al. Temporal trends on the risk of arrhythmic vs non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.
Eur Heart J. 2005;26(14):1385-139315914501
PubMedGoogle ScholarCrossref 15.Huikuri HV, Tapanainen JM, Lindgren K,
et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era.
J Am Coll Cardiol. 2003;42(4):652-65812932596
PubMedGoogle ScholarCrossref 16.Jordaens L, Tavernier R. Determinants of sudden death after discharge from hospital for myocardial infarction in the thrombolytic era.
Eur Heart J. 2001;22(14):1214-122511440494
PubMedGoogle ScholarCrossref 17.Mäkikallio TH, Barthel P, Schneider R,
et al. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy.
Am J Cardiol. 2006;97(4):480-48416461041
PubMedGoogle ScholarCrossref 18.Rouleau JL, Talajic M, Sussex B,
et al. Myocardial infarction patients in the 1990s–their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study.
J Am Coll Cardiol. 1996;27(5):1119-11278609330
PubMedGoogle ScholarCrossref 19.Steg PG, Lopez-Sendon J, Lopez de Sa E,
et al. GRACE Investigators. External validity of clinical trials in acute myocardial infarction.
Arch Intern Med. 2007;167(1):68-7317210880
PubMedGoogle ScholarCrossref 20.Hohnloser SH, Gersh BJ. Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator.
Circulation. 2003;107(7):941-94612600904
PubMedGoogle ScholarCrossref 21.Moss AJ, Zareba W, Hall WJ,
et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
N Engl J Med. 2002;346(12):877-88311907286
PubMedGoogle ScholarCrossref 22.Hohnloser SH, Kuck KH, Dorian P,
et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
N Engl J Med. 2004;351(24):2481-248815590950
PubMedGoogle ScholarCrossref 23.Wilber DJ, Zareba W, Hall WJ,
et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction.
Circulation. 2004;109(9):1082-108414993128
PubMedGoogle ScholarCrossref 24.Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: structure, function, and time-dependence of risk.
Circulation. 1992;85(1):(suppl)
I2-I101728501
PubMedGoogle Scholar 25.Salukhe TV, Dimopoulos K, Sutton R, Coats AJ, Piepoli M, Francis DP. Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications.
Circulation. 2004;109(15):1848-185315066946
PubMedGoogle ScholarCrossref 26.Roger VL, Killian J, Henkel M,
et al. Coronary disease surveillance in Olmsted County: objectives and methodology.
J Clin Epidemiol. 2002;55(6):593-60112063101
PubMedGoogle ScholarCrossref 27.White AD, Folsom AR, Chambless LE,
et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience.
J Clin Epidemiol. 1996;49(2):223-2338606324
PubMedGoogle ScholarCrossref 28.Prineas R, Crow R, Blackbur H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurements and Classification. Liettleton, MA: Wright-PSG; 1982
29.Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
J Chronic Dis. 1987;40(5):373-3833558716
PubMedGoogle ScholarCrossref 30.Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study.
J Am Coll Cardiol. 1993;22(4):(suppl A)
6A-13A8376698
PubMedGoogle ScholarCrossref 31.Goraya TY, Jacobsen SJ, Kottke TE, Frye RL, Weston SA, Roger VL. Coronary heart disease death and sudden cardiac death: a 20-year population-based study.
Am J Epidemiol. 2003;157(9):763-77012727669
PubMedGoogle ScholarCrossref 32.Jokhadar M, Jacobsen SJ, Reeder GS, Weston SA, Roger VL. Sudden death and recurrent ischemic events after myocardial infarction in the community.
Am J Epidemiol. 2004;159(11):1040-104615155288
PubMedGoogle ScholarCrossref 33.Goraya TY, Jacobsen SJ, Belau PG, Weston SA, Kottke TE, Roger VL. Validation of death certificate diagnosis of out-of-hospital coronary heart disease deaths in Olmsted County, Minnesota.
Mayo Clin Proc. 2000;75(7):681-68710907382
PubMedGoogle Scholar 34.Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.
Stat Med. 1999;18(6):695-70610204198
PubMedGoogle ScholarCrossref 35.Bardy GH, Lee KL, Mark DB,
et al. Home use of automated external defibrillators for sudden cardiac arrest.
N Engl J Med. 2008;358(17):1793-180418381485
PubMedGoogle ScholarCrossref 36.Bunch TJ, Hohnloser SH, Gersh BJ. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
Circulation. 2007;115(18):2451-245717485594
PubMedGoogle ScholarCrossref 37.Guidry UC, Evans JC, Larson MG, Wilson PW, Murabito JM, Levy D. Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study.
Circulation. 1999;100(20):2054-205910562260
PubMedGoogle ScholarCrossref 38.Hellermann JP, Goraya TY, Jacobsen SJ,
et al. Incidence of heart failure after myocardial infarction: is it changing over time?
Am J Epidemiol. 2003;157(12):1101-110712796046
PubMedGoogle ScholarCrossref 39.Bursi F, Weston SA, Killian JM, Gabriel SE, Jacobsen SJ, Roger VL. C-reactive protein and heart failure after myocardial infarction in the community.
Am J Med. 2007;120(7):616-62217602936
PubMedGoogle ScholarCrossref 40.Spencer FA, Meyer TE, Goldberg RJ,
et al. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective.
J Am Coll Cardiol. 1999;34(5):1378-138710551682
PubMedGoogle ScholarCrossref 41.Singh JP, Hall WJ, McNitt S,
et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
J Am Coll Cardiol. 2005;46(9):1712-172016256874
PubMedGoogle ScholarCrossref 42.Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact.
Circulation. 1998;97(15):1514-15219576433
PubMedGoogle ScholarCrossref 43.Devlin G, Anderson FA, Heald S,
et al. Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry.
Heart. 2005;91(11):1394-139915761048
PubMedGoogle ScholarCrossref 44.Fox KA, Anderson FA Jr, Dabbous OH,
et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE).
Heart. 2007;93(2):177-18216757543
PubMedGoogle ScholarCrossref 45.Vaccarino V, Rathore SS, Wenger NK,
et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002.
N Engl J Med. 2005;353(7):671-68216107620
PubMedGoogle ScholarCrossref 46.Wiviott SD, Morrow DA, Frederick PD, Antman EM, Braunwald E. Application of the thrombolysis in myocardial infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.
J Am Coll Cardiol. 2006;47(8):1553-155816630990
PubMedGoogle ScholarCrossref 47.Rogers WJ, Canto JG, Lambrew CT,
et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3.
J Am Coll Cardiol. 2000;36(7):2056-206311127441
PubMedGoogle ScholarCrossref 48.Steg PG, Goldberg RJ, Gore JM,
et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE).
Am J Cardiol. 2002;90(4):358-36312161222
PubMedGoogle ScholarCrossref 49.Watkins S, Thiemann D, Coresh J, Powe N, Folsom AR, Rosamond W. Fourteen-year (1987 to 2000) trends in the attack rates of, therapy for, and mortality from non-ST-elevation acute coronary syndromes in four United States communities.
Am J Cardiol. 2005;96(10):1349-135516275176
PubMedGoogle ScholarCrossref 51.Lloyd-Jones DM, Tian L. Predicting cardiovascular risk: so what do we do now?
Arch Intern Med. 2006;166(13):1342-134416831997
PubMedGoogle ScholarCrossref 52.Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
Stat Med. 2008;27(2):157-17217569110
PubMedGoogle ScholarCrossref